Effect of aspirin on plasma fibrinolytic activity in patients of coronary heart disease
Jain, A.; Mehrotra, T.N.; Goel, V.K.; Mehrotra, M.L.; Raka, M.S.
Journal of the Association of Physicians of India 30(7): 441-443
1982
ISSN/ISBN: 0004-5772 PMID: 7169468 Document Number: 193992
Document emailed within 1 workday
Related Documents
Mamont, B.; Szczepański, M. 1986: Fibrinolytic activity of the plasma euglobulin fraction in men with coronary disease (under age 60) Kardiologia Polska 29(10): 698-701Earnshaw, J.J.; Westby, J.C.; Hopkinson, B.R.; Makin, G.S. 1988: Resting plasma fibrinolytic activity and fibrinolytic potential in peripheral vascular disease Journal of Cardiovascular Surgery 29(3): 300-305
Mäurer, W.; Opherk, D.; Zebe, H.; Mehmel, H.C.; Müller, J.H.; Kübler, W. 1976: Changes of plasma-catecholamine-level in the coronary sinus of patients with coronary heart disease under stress Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1193-1196
Grinshteĭn, I.I.; Savchenko, A.A.; Grinshteĭn, I.I.; Savchenko, E.A. 2008: Peculiarities of hemostasis, metabolic activity of platelets, and rate of aspirin resistance in patients with chronic heart failure after aorto-coronary bypass surgery Kardiologiia 48(6): 51-56
Cherkanova, M.S.; Korolenko, T.A.; Bravve, I.I.; Gerasimova, T.P. 2012: Effect of statins on activity of matrix metalloproteases and serum concentration of cystatin C in patients with various risk of development of ischemic heart disease and in patients after coronary artery bypass surgery Kardiologiia 52(2): 23-28
1980: Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group Circulation 62(3): 449-461
Pignone, M.; Mulrow, C. 2002: Antiplatelet therapy and atherosclerotic events. Risks and patients' values need to be included in decision about aspirin for prevention of coronary heart disease Bmj 324(7342): 917
Liu, H.; Chen, Z.; Gao, R. 1995: Effects of low dose aspirin on platelet function and prostaglandins metabolism in systemic and coronary circulation in patients with ischemia heart disease Zhonghua Nei Ke Za Zhi 34(9): 595-598
Samsonov, M.A.; Tsagikian, T.A.; Frolova, I.A.; Meshcheriakova, V.A.; Paramonova, E.G. 1984: Effect of diet therapy on indices of the activity of the plasma kallikrein-kinin system of young and middle-aged ischemic heart disease patients Voprosy Pitaniia 5: 11-15
He, W.J.; Hu, Y.; Zhang, X.P.; Hong, M.; Guo, T.; Wei, W.N.; Song, S.J. 2008: Activated protein C ratio, plasma tissue factor activity and activated factor VIi in Chinese patients with coronary heart disease European Journal of Medical Research 13(2): 47-51
Poplawski, A.; Glowínski, S. 1974: The effect of heparin on the plasma fibrinolytic activity Acta Physiologica Polonica 25(1): 39-42
Li, X.; Zhao, S.; Li, Y.; Wang, Z.; Luo, L.; Zhou, H. 1998: Changes of plasma testosterone level in male patients with coronary heart disease Hunan Yi Ke da Xue Xue Bao 23(1): 53-56
Lwvin, G.I. 1976: Effect of the preservative TsOLIPK No. 7b on the fibrinolytic activity of cadaveric plasma Problemy Gematologii i Perelivaniia Krovi 21(3): 33-35
Canner, P.L. 1983: Aspirin in coronary heart disease. Comparison of six clinical trials Israel Journal of Medical Sciences 19(5): 413-423
Zhu, T.; Wang, Z.; Zhao, S. 1998: Effect of apolipoprotein e gene plasma levels of lipids, lipoproteins, apolipoproteins and its relation with coronary heart disease Hunan Yi Ke da Xue Xue Bao 23(2): 149-151
Zuch, A.; Darewicz, J.; Kopecki, H. 1977: Blood plasma fibrinolytic activity in patients with nephrolithiasis Polski Tygodnik Lekarski 32(16): 585-588
Lu, G.; Ouyang, S.; Pei, Z. 1999: Changes of erythrocyte membrane ATPase activities and plasma lipids in patients with coronary heart disease Hunan Yi Ke da Xue Xue Bao 24(1): 68-70
Sima, A.; Stancu, C.; Starodub, O.; Cristea, C.; Simionescu, M. 1997: Immunodetection of modified lipoproteins in plasma and arterial walls of patients with coronary heart disease Romanian Journal of Internal Medicine 35(1-4): 29-38
Keyser, R.E.; DeLaFuente, K.; McGee, J. 1993: Arm and leg cycle cross-training effect on anaerobic threshold and heart rate in patients with coronary heart disease Archives of Physical Medicine and Rehabilitation 74(3): 276-280
Lindbloom, E.J.; Eaton, L.J. 2002: Cost effectiveness of aspirin vs clopidogrel for secondary prevention of coronary heart disease Journal of Family Practice 51(9): 789